Recent studies suggest that the majority of the human genome is transcribed, but only about 2% accounts for proteincoding exons. Long noncoding RNAs (lncRNAs) constitute a heterogenic class of RNAs that includes, for example, intergenic lncRNAs, antisense transcripts, and enhancer RNAs. Moreover, alternative splicing can lead to the formation of circular RNAs. In support of putative functions, GWAS for cardiovascular diseases have shown predictive singlenucleotide polymorphisms in lncRNAs, such as the 9p21 susceptibility locus that encodes the lncRNA antisense noncoding RNA in the INK4 locus (ANRIL). Many lncRNAs are regulated during disease. For example, metastasis-associated lung adenocarcinoma transcript 1 (MALAT1) and myocardial infarction-associated transcript (MIAT) were shown to affect endothelial cell functions and diabetic retinopathy, whereas lincRNA-p21 controls neointima formation. In the heart, several lncRNAs were shown to act as microRNA sponges and to control ischemia-reperfusion injury or act as epigenetic regulators. In this review, the authors summarize the current understanding of lncRNA functions and their role as biomarkers in cardiovascular diseases. (J Am Coll Cardiol 2016;67:1214-26) 
I
n the early days of molecular biology, the categorization of ribonucleic acids (RNAs) was relatively straightforward, dividing RNAs into protein-coding messenger RNAs (mRNAs) and a reasonable number of functional noncoding RNAs, such as transfer RNAs or ribosomal RNAs. However, by comparing the sizes of haploid genomes (C values) from different organisms, it was soon discovered that these values do not necessarily correlate with developmental complexity (1) . The assumption was that the majority of the genome is noncoding DNA or "junk" DNA (2) . Nevertheless, this supposed nonfunctionality was already questioned at this time (1) , and subsequent RNA-driven hybridization reactions with nonrepetitive sea urchin DNA revealed that socalled heterogeneous nuclear RNA covers a larger portion of the genome than mRNA isolated from polysomal fractions (3) . This obvious imbalance between RNA being transcribed and known RNA species was solved stepwise by the discovery of intronic sequences (4, 5) and various functional noncoding RNAs, such as the RNA component of RNaseP (6), small nuclear RNAs (7), longer noncoding transcripts (e.g., Xist and H19 [8, 9] ), and microRNAs (miRNAs) (10) (Figure 1A) . Meanwhile, the biogenesis and function of many of these noncoding RNAs is well described. MiRNAs, for example, are small cytoplasmic RNAs of 20 to 23 nt in length exhibiting an important gene-regulatory potential. They are transcribed as primary transcripts, processed to precursors in the nucleus, and subsequently exported to the cytoplasm to be diced into mature doublestranded miRNAs. Of this duplex, 1 strand is incorporated into RNA-induced silencing complexes to silence gene expression at the post-transcriptional level (see He et al. [11] for a detailed review). In contrast, small nuclear RNAs are part of small nuclear ribonucleoproteins, which participate in the dynamic From the a Institute for Cardiovascular Regeneration, University of Frankfurt, Frankfurt, Germany; b assembly of the spliceosome on nascent pre-mRNAs and the process of splicing (12) . Finally, with the advent of next-generation sequencing technologies, it became evident that the human genome is nearly pervasively transcribed, which means that the majority of its bases are associated with at least 1 primary transcript (13, 14) ; however, protein-coding exons account for only about 2% of the genome (15, 16) .
Today, long noncoding RNAs (lncRNAs) are frequently defined as non-protein-coding transcripts larger than 200 nt to distinguish them from small noncoding RNAs (17) ; however, their classification is not standardized. Accordingly, lncRNA nomenclature relies on diverse empirical features, for example, origin of transcription, tissue specificity, molecular function, or mechanism of action (see Ma et al. [18] for a detailed review). Regarding their genomic localization, lncRNAs can be transcribed from intergenic regions (long intervening noncoding RNAs), from within introns of protein-coding genes (intronic lncRNAs), or from the antisense strand of a given gene (natural antisense transcripts) (19) . Interestingly, the primary sequence of lncRNAs is only poorly conserved; however, this circumstance is partially compensated by a higher degree of structural conservation (20) to maintain functionality (21) .
Frequently, lncRNAs are also transcribed from conserved genomic regions (same order of flanking genes in different species), indicating a putative functional relation, despite the previously mentioned sequence divergence (22). Back-splicing of exons, thereby forming circular RNAs (circRNAs), can also generate lncRNAs (23, 24) . In contrast to the previously described lncRNAs, circRNAs are better conserved and are more stable because of their resistance to exonucleases (24, 25) .
LncRNA molecular functions are very diverse (Central Illustration). One of the best-studied aspects is their role in the epigenetic regulation of allelic expression. A generic model for this is the wellknown process of X chromosome dosage compensation in female mammals. X chromosome inactivation is achieved by expression of the lncRNA Xist, which coats 1 X chromosome and acts as a scaffold for the recruitment of silencing factors (e.g., polycomb repressive complex 2 [PRC2]) (26, 27) . Related to X chromosome inactivation is the developmental process of genomic imprinting, which results in the exclusive expression of specific genes from only 1 parent chromosome (28) . In this context, the highly expressed long intervening noncoding RNA H19, now known to be part of an imprinted gene network, was among the first imprinted genes identified (9) .
Recent studies suggest that H19 interacts with Depending on the subcellular localization, long noncoding RNAs (lncRNAs) can act via various mechanisms. By mimicking transcription factor binding sites, doublestranded regions of lncRNAs can bind to transcription factors, thereby functioning as a decoy. Via binding to chromatin modifiers, lncRNAs contribute to epigenetic silencing or activation of gene expression. LncRNAs that bind to exon/intron junctions of pre-messenger RNA (mRNA) can influence (alternative) splicing. Several lncRNAs act as a scaffold in ribonucleoprotein (RNP) complexes. In the cytoplasm, numerous lncRNAs have been shown to bind microRNAs (miRNAs), thereby preventing the miRNAs from binding to and regulating their mRNA targets. By masking binding sites for proteins or miRNAs, cytoplasmic lncRNAs can alter the stability of mRNAs.
ANRIL increased adhesion and decreased apoptosis, which are proatherosclerotic cellular mechanisms (56) . At the molecular level, ANRIL binds to epigenetic effector proteins of PRC1 and PRC2 (33, 56, 59) and recruits them to promoter regions, thereby epigenetically regulating gene expression patterns (56, 60, 61) . The recruitment is mediated though repetitive Alu elements in ANRIL, which are mirrored in the promoters of its target genes (56) .
Two other studies have investigated lncRNAs at genomic loci associated with myocardial infarction and coronary artery disease (CAD) in Japanese and Chinese cohorts (62, 63) . Because these loci were not replicated in GWAS performed in populations of European descent, it remains to be determined whether these loci and lncRNAs also contribute to athero- In a Chinese population, variations of lncRNA H19 at chromosome 11p15.5 have been associated with the risk for CAD (63) . Here it was shown that subjects carrying 3 or 4 risk alleles at the H19 locus had a significantly increased risk for CAD and higher Gensini scores than those with 0 to 2 risk alleles (63) . The rs2067051 polymorphism site is located in the 5 0 flank of H19 and is near the imprinting control regions, which are critical for regulation of H19 expression.
The second SNP in the H19 locus is located in the last exon of H19, but how this contributes to H19 expression levels or function is unclear at the moment. H19
is an imprinted lncRNA, which is induced during embryogenesis and down-regulated after birth, except in adult skeletal muscle and heart. H19
expression is increased in various tumors (64) .
Moreover, H19 is highly expressed in the neointima of rats 7 to 14 days after vascular injury (65) and is reexpressed in human atherosclerotic plaques (66) . 
REGULATION OF lncRNAs IN CARDIOVASCULAR DISEASE
Because lncRNAs can be linked to cardiovascular disease, it is highly likely that lncRNAs are also regulated in certain cardiovascular disease states.
The first evidence that lncRNAs are dynamically regulated in the heart came from studies of cardiac development during embryogenesis in mice (71, 72) .
In recent years, several lncRNAs have been dimmeler@em.uni-frankfurt.de.
